NetScientific (NSCI) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Nov 2022 02:00 PM
RNS
Price Monitoring Extension
09 Nov 2022 07:00 AM
RNS
Board Change
07 Nov 2022 03:40 PM
RNS
PDS reports presentation of data at cancer society
20 Oct 2022 07:00 AM
RNS
EMV Capital secures investment in Ventive
11 Oct 2022 04:00 PM
RNS
PDS Update
03 Oct 2022 01:56 PM
RNS
PDS completes End-of-Phase 2 meeting with FDA
30 Sep 2022 07:00 AM
RNS
Half-year Report
25 Aug 2022 07:00 AM
RNS
PDS Completes $35 Million Financing Agreement
16 Aug 2022 07:00 AM
RNS
Acquisition of 30% Vortex stake & new Vortex CEO
08 Aug 2022 04:45 PM
RNS
PDS Reports Q2 2022 Results & Business Update
29 Jun 2022 02:05 PM
RNS
Result of AGM
28 Jun 2022 09:15 AM
RNS
Holding(s) in Company
27 Jun 2022 08:30 AM
RNS
Holding(s) in Company
27 Jun 2022 08:30 AM
RNS
Director/PDMR Shareholding
22 Jun 2022 07:00 AM
RNS
Result of Placing and Total Voting Rights
21 Jun 2022 04:41 PM
RNS
Proposed Placing to raise at least £1.5 million
17 Jun 2022 12:00 PM
RNS
NetScientific to increase Q-Bot stake to 23.7%
15 Jun 2022 07:00 AM
RNS
Q-Bot secures £1.6m of investment to fund growth
07 Jun 2022 11:07 AM
RNS
Notice of AGM and Annual Report & Accounts
06 Jun 2022 07:00 AM
RNS
PDS Granted FDA Fast Track Designation for PDS0101
27 May 2022 02:39 PM
RNS
PDS Biotech - new data for ongoing clinical trials
19 May 2022 07:00 AM
RNS
General Counsel Strategic Hire & Grant of Options
16 May 2022 07:00 AM
RNS
ProAxsis Update
12 May 2022 07:00 AM
RNS
Final Results
11 May 2022 03:46 PM
RNS
PDS Reports Q1 2022 Results & Business Update
09 May 2022 07:00 AM
RNS
Notice of Results & Investor Presentation
06 May 2022 07:00 AM
RNS
Acquisition of 30% of Vortex Biotech Holdings
25 Apr 2022 02:05 PM
RNS
Second Price Monitoring Extn
25 Apr 2022 02:00 PM
RNS
Price Monitoring Extension
25 Apr 2022 11:05 AM
RNS
Second Price Monitoring Extn
25 Apr 2022 11:00 AM
RNS
Price Monitoring Extension
31 Mar 2022 01:24 PM
RNS
PDS Provides Business Update & Full-Year Results
04 Mar 2022 07:30 AM
RNS
Publication of Shareholder Newsletter
24 Feb 2022 04:45 PM
RNS
PDS Announces Preliminary Safety Data on PDS0101
15 Feb 2022 02:32 PM
RNS
PDS Clinical Trial with Mayo Clinic
02 Feb 2022 03:00 PM
RNS
PDS Phase 2 Trial Update
28 Jan 2022 08:45 AM
RNS
PDS Announces Preclinical Data for PDS0202 Vaccine
18 Jan 2022 07:00 AM
RNS
Holding(s) in Company
10 Jan 2022 02:20 PM
RNS
PDS Granted Novel HPV16 Immunotherapy Patent
10 Jan 2022 07:00 AM
RNS
ProAxsis CEO End of Year Update
29 Dec 2021 08:47 AM
RNS
Issue of Equity
21 Dec 2021 01:59 PM
RNS
TR-1: Form for notification of major holdings
21 Dec 2021 07:00 AM
RNS
Q-Bot Investment and Share Acquisition
20 Dec 2021 07:00 AM
RNS
Acquisition of majority stake in Cetromed
13 Dec 2021 07:00 AM
RNS
Martlet Capital Update
06 Dec 2021 02:53 PM
RNS
PDS Phase 2 Clinical Trial Update
26 Nov 2021 07:00 AM
RNS
$1million investment in portfolio company, EpiBone
10 Nov 2021 01:58 PM
RNS
PDS Reports Q3 2021 Results & Business Update
04 Nov 2021 07:00 AM
RNS
Sofant Signs EUR7.3m ESA Contract
01 Nov 2021 02:16 PM
RNS
PDS to License Novel Proteins for Flu Vaccine
UK 100

Latest directors dealings